The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma.

dc.contributor.author

Chaudhry, Mohammad

dc.contributor.author

McGinty, Katrina A

dc.contributor.author

Mervak, Benjamin

dc.contributor.author

Lerebours, Reginald

dc.contributor.author

Li, Cai

dc.contributor.author

Shropshire, Erin

dc.contributor.author

Ronald, James

dc.contributor.author

Commander, Leah

dc.contributor.author

Hertel, Johann

dc.contributor.author

Luo, Sheng

dc.contributor.author

Bashir, Mustafa R

dc.contributor.author

Burke, Lauren MB

dc.date.accessioned

2020-01-01T15:48:22Z

dc.date.available

2020-01-01T15:48:22Z

dc.date.issued

2019-12-17

dc.date.updated

2020-01-01T15:48:22Z

dc.description.abstract

Background The Liver Imaging Reporting and Data System (LI-RADS) treatment response algorithm (TRA) is used to assess presumed hepatocellular carcinoma (HCC) after local-regional therapy, but its performance has not been extensively assessed. Purpose To assess the performance of LI-RADS version 2018 TRA in the evaluation of HCC after ablation. Materials and Methods In this retrospective study, patients who underwent ablation therapy for presumed HCC followed by liver transplantation between January 2011 and December 2015 at a single tertiary care center were identified. Lesions were categorized as completely (100%) or incompletely (≤99%) necrotic based on transplant histology. Three radiologists assessed pre- and posttreatment MRI findings using LI-RADS version 2018 and the TRA, respectively. Interreader agreement was assessed by using the Fleiss κ test. Performance characteristics for predicting necrosis category based on LI-RADS treatment response (LR-TR) category (viable or nonviable) were calculated by using generalized mixed-effects models to account for clustering by subject. Results A total of 36 patients (mean age, 58 years ± 5 [standard deviation]; 32 men) with 53 lesions was included. Interreader agreement for pretreatment LI-RADS category was 0.40 (95% confidence interval [CI]: 0.15, 0.67; P < .01) and was lower than the interreader agreement for TRA category (κ = 0.71; 95% CI: 0.59, 0.84; P < .01). After accounting for clustering by subject, sensitivity of tumor necrosis across readers ranged from 40% to 77%, and specificity ranged from 85% to 97% when LR-TR equivocal assessments were treated as nonviable. When LR-TR equivocal assessments were treated as viable, sensitivity of tumor necrosis across readers ranged from 81% to 87%, and specificity ranged from 81% to 85% across readers. Six (11%) of 53 treated lesions were LR-TR equivocal by consensus, with most (five of six) incompletely necrotic at histopathology. Conclusion The Liver Imaging Reporting and Data System treatment response algorithm can be used to predict viable or nonviable hepatocellular carcinoma after ablation. Most ablated lesions rated as treatment response equivocal were incompletely necrotic at histopathology. © RSNA, 2019 Online supplemental material is available for this article. See also the editorial by Do and Mendiratta-Lala in this issue.

dc.identifier.issn

0033-8419

dc.identifier.issn

1527-1315

dc.identifier.uri

https://hdl.handle.net/10161/19681

dc.language

eng

dc.publisher

Radiological Society of North America (RSNA)

dc.relation.ispartof

Radiology

dc.relation.isversionof

10.1148/radiol.2019191581

dc.title

The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma.

dc.type

Journal article

duke.contributor.orcid

Lerebours, Reginald|0000-0003-2884-3168

duke.contributor.orcid

Luo, Sheng|0000-0003-4214-5809

duke.contributor.orcid

Bashir, Mustafa R|0000-0001-8800-5057

pubs.begin-page

191581

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Radiology, Abdominal Imaging

pubs.organisational-group

Radiology

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Medicine, Gastroenterology

pubs.organisational-group

Medicine

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Biostatistics & Bioinformatics

pubs.organisational-group

Basic Science Departments

pubs.publication-status

Published

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2019Chaudhry_et_al2019Radiology.pdf
Size:
736.51 KB
Format:
Adobe Portable Document Format
Description:
Submitted version